Year: 2026
Type: article
Abstract: Public-private partnerships focused on infectious disease diagnostics have been increasing since the COVID-19 pandemic. These partnerships have resulted in new test development, increased testing capacity and services, technology development, and processes to enable faster collaborative response in the context of an outbreak. This paper explores the importance of public-private partnerships in response to infectious disease public health threats. Collaboration between federal partners and diagnostic test manufacturers has been critical to the COVID-19, mpox, and other responses in the United States, and these partnerships will be critical to future responses. Public-private partnerships pull together the pieces needed to rapidly develop and scale diagnostics necessary for responding to emerging infectious diseases. Developing partnerships during "peace time" further enables rapid action when outbreaks occur.
Source: Frontiers in Public Health
Institution: Cepheid (United States)
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7124157002